Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination

Annals of Neurology
M K StorchH Lassmann

Abstract

We describe a case of multiple sclerosis characterized by deposition of immunoglobulin and complement in the areas of active demyelination. This was particularly evident for the C9neo antigen, which is a marker for the activated lytic complement complex and was exclusively deposited in the areas of active myelin destruction. In addition, macrophages in the lesions contained degradation products that were immunoreactive for myelin antigens, immunoglobulins, and C9neo antigen. Destruction of myelin sheaths was associated with incomplete loss of oligodendrocytes in the active areas and reappearance of oligodendrocytes with remyelination in the inactive plaque center.

References

Aug 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·K SelmajC S Raine
Jul 1, 1989·Neuropathology and Applied Neurobiology·D A CompstonB Jasani
Apr 1, 1988·Annals of Neurology·K W Selmaj, C S Raine
May 21, 1971·Brain Research·C E Lumsden
Jul 1, 1980·Neurology·I Grundke-Iqbal, M B Bornstein
Nov 1, 1995·Annals of Neurology·W BrückH Lassmann
Mar 1, 1995·Journal of Neuropathology and Experimental Neurology·R A SobelJ R Hinojoza
Dec 1, 1994·Brain : a Journal of Neurology·K OzawaH Lassmann
Mar 1, 1993·Journal of Neuropathology and Experimental Neurology·E WuC S Raine
Jul 1, 1993·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·R GoldH Lassmann

❮ Previous
Next ❯

Citations

Aug 12, 1999·Annals of Neurology·H F McFarland
Nov 15, 2001·Annals of Neurology·J W PrineasB P Morgan
Nov 17, 2004·Annals of Neurology·Diana L VargasCarlos A Pardo
Jun 3, 2010·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Martin J RutkowskiAndrew T Parsa
Nov 16, 2007·Journal of Neurology·Christoph KleinschnitzHeinz Wiendl
Mar 21, 2007·Bulletin of Experimental Biology and Medicine·E G SorokinaV G Pinelis
Aug 19, 2011·Journal of Clinical Immunology·Oliver CrespoWilliam H Robinson
Oct 26, 2007·Immunologic Research·Sangjin OhHorea Rus
Mar 24, 2004·Trends in Immunology·Hans Lassmann, Richard M Ransohoff
May 4, 2005·Trends in Immunology·Antonio UccelliVito Pistoia
Jan 31, 2004·Neurobiology of Disease·Gabor G KovacsMarin Guentchev
Oct 22, 2003·Progress in Neurobiology·Yong Shen, Seppo Meri
Feb 1, 2003·Journal of the Neurological Sciences·Per Soelberg Sorensen
Dec 14, 2002·Journal of the Neurological Sciences·Permphan Dharmasaroja
Jul 30, 1999·Journal of the Neurological Sciences·F O AkenamiA Vaheri
Dec 8, 2000·Journal of Neuroimmunology·A H CrossJ Lyons
Apr 19, 2002·Journal of Neuroimmunology·Margaret M Morris-DownesSandra Amor
Sep 25, 1999·Journal of Neuroimmunology·J ChatawayA Compston
Jun 17, 2000·Trends in Neurosciences·J J Archelos, H P Hartung
Nov 18, 1998·Immunology Today·J D LamanL Kappos
Aug 12, 2003·Brain Research Bulletin·Barbara Kornek, Hans Lassmann
Jan 13, 2000·Neuropathology and Applied Neurobiology·J E Merrill, N J Scolding
Jul 26, 2000·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·B G Weinshenker
Sep 28, 2000·The New England Journal of Medicine·J H NoseworthyB G Weinshenker
Jul 11, 2003·The New England Journal of Medicine·Thomas BergerMarkus Reindl
Jul 13, 2012·The New England Journal of Medicine·Rajneesh SrivastavaBernhard Hemmer
Nov 9, 2002·The Journal of Infectious Diseases·M Mateo Paz Soldan, Moses Rodriguez
Feb 3, 2005·Journal of Neurotrauma·Aileen J AndersonCarl W Cotman
Mar 14, 2007·The Neurologist·Sean J Pittock, Claudia F Lucchinetti
Apr 27, 2007·Journal of Virology·Jan D LünemannChristian Münz
May 18, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·S RauerTh Berger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.